# Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

> **NCT07319286** · PHASE1,PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Menstrual Irregularities
- Type1 Diabetes Mellitus
- Glucagon-Like Peptide-1 Receptor Agonists
- Female Reproductive Health

## Interventions

- **DRUG:** Dulaglutide

## Key facts

- **NCT ID:** NCT07319286
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-08-04
- **Primary completion:** 2026-04
- **Final completion:** 2026-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07319286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07319286, "Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07319286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*